22 Nov 2019 | 6:57 PM
Research Report
Daily

Equity Research Report: Religare Morning Digest

Nifty has almost reached closer to crucial hurdle of 10,950 and its decisive break would pave the way for further up move. The recent outperformance from banking space is indeed an encouraging sign. However, we suggest not going overboard and maintaining focus on stock selection.
18 Dec 2018 | 07:00 AM

  • Power Mech Project bagged orders worth Rs 245cr. The company received order worth Rs 136cr for structural and architectural work of Main Plant Area of Unit 1 at 2x800 MW Uppur Super Critical Thermal Power Project, Tamil Nadu. Another order worth Rs 109cr was received for operations and maintenance of 2x800 MW Coal based Yeramarus Thermal Power Station, Karnataka.
  • Lupin received USFDA approval for Clobazam Tablets which is a generic version of Lundbeck Pharmaceuticals, LLC's Onfi Tablets. The drug is indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.
  • Vedanta announced that it received approval from National Green Tribunal (NGT) to reopen its Sterlite Copper plant in Tuticorin, Tamil Nadu. Tamil Nadu Pollution Control Board has also been directed to pass fresh order of renewal of consent and restoration of electricity supply for its operations within 3 weeks.